NHS England 7 July 2018
- Treatments approved through NHS England’s latest specialised commissioning prioritisation.
- Treatments are grouped into five levels of priority, with those that cost less and offer more clinical benefit for patients relative to the other treatments being considered classified as level one, and treatments with the lowest relative clinical benefit and highest cost placed in the lowest category (level five).
Teriparatide for osteoporosis in men
Level 2:
Anakinra and tocilizumab for adult onset stills disease
Anakinra for autoinflammatory
Keraprosthesis for corneal blindness
Left Atrial Appendage Occlusion for patients with atrial fibrillation and relative or absolute contraindications to anticoagulation (adults)
Susoctocog alfa for acquired haemophilia A
Level 3:
Bendamustine with rituximab for first line treatment of advanced indolent non-hodgkins lymphoma
Bendamustine with rituximab for the treatment of relapsed mantle cell lymphoma
Selective dorsal rhizotomy
Lomitapide for homozygous familial hypercholesterolemia
Total pancreatectomy with islet transplantation for chronic pancreatitis
Level 4:
Human coagulation factor X for hereditary factor X deficiency
Selexipag for pulmonary arterial hypertension
Level 5:
Everolimus for refractory seizures associated with tuberous sclerosis complex
Level 2:
Anakinra and tocilizumab for adult onset stills disease
Anakinra for autoinflammatory
Keraprosthesis for corneal blindness
Left Atrial Appendage Occlusion for patients with atrial fibrillation and relative or absolute contraindications to anticoagulation (adults)
Susoctocog alfa for acquired haemophilia A
Level 3:
Bendamustine with rituximab for first line treatment of advanced indolent non-hodgkins lymphoma
Bendamustine with rituximab for the treatment of relapsed mantle cell lymphoma
Selective dorsal rhizotomy
Lomitapide for homozygous familial hypercholesterolemia
Total pancreatectomy with islet transplantation for chronic pancreatitis
Level 4:
Human coagulation factor X for hereditary factor X deficiency
Selexipag for pulmonary arterial hypertension
Level 5:
Everolimus for refractory seizures associated with tuberous sclerosis complex
The following treatments and services will also be routinely commissioned with immediate effect:
Emicizumab as prophylaxis in people with congenital haemophilia A with factor VIII inhibitors.
Bendamustine with rituximab for first line treatment of mantle cell lymphoma in adults.
Service specification DNA nucleotide excision repair disorders services.
Emicizumab as prophylaxis in people with congenital haemophilia A with factor VIII inhibitors.
Bendamustine with rituximab for first line treatment of mantle cell lymphoma in adults.
Service specification DNA nucleotide excision repair disorders services.
